Mary Rozenman
Login to view DISC.Mary Rozenman is the CFO and CBO of insitro, where she leads finance, corporate strategy, and business development. A Harvard Ph. D. graduate, she was a founding team member at Aimmune Therapeutics, which developed the first approved drug for peanut allergy and was acquired by Nestlé Health Sciences for $2. 6B.
Outside of work, Mary enjoys cooking, hiking, golf, and theater. She is passionate about mentoring and creating opportunities for women in the biotech industry, serving on the Lifescience Council for Springboard Enterprises to support women-led companies. She balances her career with her family, including her husband and two children.
Unique fact: She holds a B. A. from Columbia University in both Biochemistry and Russian Literature, showcasing her diverse intellectual interests beyond science.
Read the full overview →How Mary shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Mary cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.